2024 annual financial data
Aprea Therapeutics 2024 Net margin
Direct answer
Net margin was -862.43%.
Operating income was -14,319,655 USD and net income was -12,958,711 USD.
Operating cash flow was -13,556,718 USD.
Get free Aprea Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,502,581 USD
- Operating income
- -14,319,655 USD
- Net income
- -12,958,711 USD
- Operating cash flow
- -13,556,718 USD